Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q2 2024 Earnings

9MayConfirmed

Q4 2023

Q2 2024

-3.75

-2.72

-1.7

-0.67

Details

Expected EPS

-0.9725474976

Actual EPS

-1.11264

Surprise EPS

-0.14

Surprise Percent

+14.4%

Description

Spyre Therapeutics (3920.F) has reported earnings of -1.11264 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.